Issued Patents All Time
Showing 25 most recent of 31 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12318458 | PSMA-targeting ligands with optimal properties for imaging and therapy | Reinier Hernandez | 2025-06-03 |
| 12156921 | PSMA-targeting ligands with optimal properties for imaging and therapy | Reinier Hernandez | 2024-12-03 |
| 12109256 | Radiohalogenated agents for in situ immune modulated cancer vaccination | Jamey P. Weichert, Paul Sondel, Zachary Morris, Mario Otto, Bryan Bednarz | 2024-10-08 |
| 11739174 | Cationic cyclic amine and amphipathic transfection reagents | Nicholas A. A. Rossi, Karen Neder, James Ludtke, Laura Juckem | 2023-08-29 |
| 11730834 | Targeted radiotherapy chelates for in situ immune modulated cancer vaccination | Jamey P. Weichert, Paul Sondel, Zachary Morris, Mario Otto, Bryan Bednarz +1 more | 2023-08-22 |
| 11623007 | Long-lived gadolinium based tumor targeted imaging and therapy agents | Jamey P. Weichert, Wolfgang Axel Tomé | 2023-04-11 |
| 11467159 | Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells | Jamey P. Weichert, Chorom Pak, Kevin Kozak, Marc Longino | 2022-10-11 |
| 11439709 | Phospholipid ether analogs as cancer-targeting drug vehicles | Jamey P. Weichert, Kevin Kozak, Marc Longino, Joseph Grudzinski, Benjamin Titz +2 more | 2022-09-13 |
| 11186598 | Radioactive phospholipid metal chelates for cancer imaging and therapy | Jamey P. Weichert, Reinier Hernandez | 2021-11-30 |
| 10813998 | Long-lived gadolinium based tumor targeting imaging and therapy agents | Jamey P. Weichert, Wolfgang Axel Tomé | 2020-10-27 |
| 10751430 | Targeted radiotherapy chelates for in situ immune modulated cancer vaccination | Jamey P. Weichert, Paul Sondel, Zachary Morris, Mario Otto, Bryan Bednarz +1 more | 2020-08-25 |
| 10736949 | Radiohalogenated agents for in situ immune modulated cancer vaccination | Jamey P. Weichert, Paul Sondel, Zachary Morris, Mario Otto, Bryan Bednarz | 2020-08-11 |
| 10265398 | Long-lived gadolinium based tumor targeted imaging and therapy agents | Jamey P. Weichert, Wolfgang Axel Tomé | 2019-04-23 |
| 10004818 | Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer | Jamey P. Weichert, Irawati Kandela, Marc Longino, William R. Clarke | 2018-06-26 |
| 9925269 | Phospholipid ether analogs as cancer-targeting drug vehicles | Jamey P. Weichert, Kevin Kozak, Marc Longino, Joseph Grudzinski, Benjamin Titz +2 more | 2018-03-27 |
| 9616140 | Fluorescent phospholipid ether compounds, compositions, and methods of use | Jamey P. Weichert, Marc Longino, Irawati Kandela, William R. Clarke | 2017-04-11 |
| 9579406 | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof | Jamey P. Weichert, Marc Longino | 2017-02-28 |
| 9550002 | Phospholipid analogs as diapeutic agents and methods thereof | Jamey P. Weichert, Marc Longino | 2017-01-24 |
| 9480754 | Phospholipid ether analogs as cancer-targeting drug vehicles | Jamey P. Weichert, Kevin Kozak, Marc Longino, Joseph Grudzinski, Benjamin Titz +2 more | 2016-11-01 |
| 9345718 | Phospholipid ether analogs as cancer-targeting drug vehicles | Jamey P. Weichert, Kevin Kozak, Marc Longino, Joseph Grudzinski, Benjamin Titz +2 more | 2016-05-24 |
| 9339564 | Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer | Jamey P. Weichert, Irawati Kandela, Marc Longino, William R. Clarke | 2016-05-17 |
| 8877160 | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof | Jamey P. Weichert, Marc Longino | 2014-11-04 |
| 8877159 | Phospholipid analogs as diapeutic agents and methods thereof | Jamey P. Weichert, Marc Longino | 2014-11-04 |
| 8871181 | Fluorescent phospholipid ether compounds, compositions, and methods of use | Jamey P. Weichert, Marc Longino, Irawati Kandela, William R. Clarke | 2014-10-28 |
| 8540968 | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof | Jamey P. Weichert, Marc Longino | 2013-09-24 |